These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2841742)

  • 1. [Double-blind randomized comparative study of enoxaparin and standard heparin in the prevention of thromboembolic disease during insertion of total hip replacement].
    Planes A; Vochelle N; Mazas F; Mansat C; Zucman G; Landais A; Weill D; Pascariello JC; Butel J
    Rev Med Interne; 1988; 9(3):327-33. PubMed ID: 2841742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of postoperative venous thrombosis: a randomized trial comparing unfractionated heparin with low molecular weight heparin in patients undergoing total hip replacement.
    Planes A; Vochelle N; Mazas F; Mansat C; Zucman J; Landais A; Pascariello JC; Weill D; Butel J
    Thromb Haemost; 1988 Dec; 60(3):407-10. PubMed ID: 2853459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
    Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
    Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of deep vein thrombosis with low molecular-weight heparin in patients undergoing total hip replacement. A randomized trial. The German Hip Arthroplasty Trial (GHAT) Group.
    Arch Orthop Trauma Surg; 1992; 111(2):110-20. PubMed ID: 1314065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative trial of a low molecular weight heparin (enoxaparin) versus standard heparin for the prophylaxis of postoperative deep vein thrombosis in general surgery.
    Nurmohamed MT; Verhaeghe R; Haas S; Iriarte JA; Vogel G; van Rij AM; Prentice CR; ten Cate JW
    Am J Surg; 1995 Jun; 169(6):567-71. PubMed ID: 7771617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement.
    Bergqvist D; Benoni G; Björgell O; Fredin H; Hedlundh U; Nicolas S; Nilsson P; Nylander G
    N Engl J Med; 1996 Sep; 335(10):696-700. PubMed ID: 8703168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of thromboembolism in 190 hip arthroplasties. Comparison of LMW heparin and placebo.
    Lassen MR; Borris LC; Christiansen HM; Boll KL; Eiskjaer SP; Nielsen BW; Schøtt P; Olsen AD; Rodenberg JC; Lucht U
    Acta Orthop Scand; 1991 Feb; 62(1):33-8. PubMed ID: 1848385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of deep vein thrombosis after elective hip surgery. A randomized trial comparing low molecular weight heparin with standard unfractionated heparin.
    Levine MN; Hirsh J; Gent M; Turpie AG; Leclerc J; Powers PJ; Jay RM; Neemeh J
    Ann Intern Med; 1991 Apr; 114(7):545-51. PubMed ID: 1848054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
    Kakkar VV; Howes J; Sharma V; Kadziola Z
    Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevention of deep vein thrombosis by enoxaparin after total hip prosthesis].
    Vochelle N; Planes A
    Agressologie; 1990 Mar; 31(3):145-8. PubMed ID: 2173435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of enoxaparin, a low-molecular-weight heparin, and unfractionated heparin for the prevention of deep venous thrombosis after elective hip replacement. A clinical trial comparing efficacy and safety. Enoxaparin Clinical Trial Group.
    Colwell CW; Spiro TE; Trowbridge AA; Morris BA; Kwaan HC; Blaha JD; Comerota AJ; Skoutakis VA
    J Bone Joint Surg Am; 1994 Jan; 76(1):3-14. PubMed ID: 8288662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of deep-vein thrombosis and pulmonary embolism after total hip replacement. Comparison of low-molecular-weight heparin and unfractionated heparin.
    Eriksson BI; Kälebo P; Anthymyr BA; Wadenvik H; Tengborn L; Risberg B
    J Bone Joint Surg Am; 1991 Apr; 73(4):484-93. PubMed ID: 2013587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of thromboembolism with use of recombinant hirudin. Results of a double-blind, multicenter trial comparing the efficacy of desirudin (Revasc) with that of unfractionated heparin in patients having a total hip replacement.
    Eriksson BI; Ekman S; Lindbratt S; Baur M; Bach D; Torholm C; Kälebo P; Close P
    J Bone Joint Surg Am; 1997 Mar; 79(3):326-33. PubMed ID: 9070519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of enoxaparin in prevention of deep venous thrombosis in hip and knee surgery--a comparison with the dihydroergotamine-heparin combination.
    Perhoniemi V; Vuorinen J; Myllynen P; Kivioja A; Lindevall K
    Ann Chir Gynaecol; 1996; 85(4):359-63. PubMed ID: 9014067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin.
    Leyvraz PF; Bachmann F; Hoek J; Büller HR; Postel M; Samama M; Vandenbroek MD
    BMJ; 1991 Sep; 303(6802):543-8. PubMed ID: 1655136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of postdischarge administration of enoxaparin in the prevention of deep venous thrombosis after total hip replacement. A prospective randomised double-blind placebo-controlled trial.
    Planes A; Vochelle N; Darmon JY; Fagola M; Bellaud M; Compan D; Saliba E; Weisslinger N; Huet Y
    Drugs; 1996; 52 Suppl 7():47-54. PubMed ID: 9042560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-molecular-weight heparin (enoxaparin) vs dextran 70. The prevention of postoperative deep vein thrombosis after total hip replacement. The Danish Enoxaparin Study Group.
    Arch Intern Med; 1991 Aug; 151(8):1621-4. PubMed ID: 1714709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low molecular weight heparin (enoxaparin) compared with unfractionated heparin in prophylaxis of deep venous thrombosis and pulmonary embolism in patients undergoing hip replacement.
    Avikainen V; von Bonsdorff H; Partio E; Kaira P; Hakkinen S; Usenius JP; Kaaja R
    Ann Chir Gynaecol; 1995; 84(1):85-90. PubMed ID: 7645915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylaxis for the prevention of venous thromboembolism after total knee arthroplasty. A comparison between unfractionated and low-molecular-weight heparin.
    Faunø P; Suomalainen O; Rehnberg V; Hansen TB; Krøner K; Soimakallio S; Nielsen E
    J Bone Joint Surg Am; 1994 Dec; 76(12):1814-8. PubMed ID: 7989386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. Enoxaparin Clinical Trial Group.
    Comp PC; Spiro TE; Friedman RJ; Whitsett TL; Johnson GJ; Gardiner GA; Landon GC; Jové M;
    J Bone Joint Surg Am; 2001 Mar; 83(3):336-45. PubMed ID: 11263636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.